Cargando…
Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645556/ http://dx.doi.org/10.1186/2051-1426-3-S2-P90 |
| _version_ | 1782400839346814976 |
|---|---|
| author | Gustafson, Michael Lin, Yi Gastineau, Dennis Parney, Ian Dietz, Allan |
| author_facet | Gustafson, Michael Lin, Yi Gastineau, Dennis Parney, Ian Dietz, Allan |
| author_sort | Gustafson, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645556 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46455562015-11-20 Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies Gustafson, Michael Lin, Yi Gastineau, Dennis Parney, Ian Dietz, Allan J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645556/ http://dx.doi.org/10.1186/2051-1426-3-S2-P90 Text en Copyright © 2015 Gustafson et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Gustafson, Michael Lin, Yi Gastineau, Dennis Parney, Ian Dietz, Allan Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies |
| title | Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies |
| title_full | Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies |
| title_fullStr | Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies |
| title_full_unstemmed | Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies |
| title_short | Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies |
| title_sort | using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645556/ http://dx.doi.org/10.1186/2051-1426-3-S2-P90 |
| work_keys_str_mv | AT gustafsonmichael usingwholeimmunesystemcharacterizationimmuneprofilingtoidentifyimmunebiomarkerstodeterminepatientselectiondosingandefficacyofnewimmunetherapies AT linyi usingwholeimmunesystemcharacterizationimmuneprofilingtoidentifyimmunebiomarkerstodeterminepatientselectiondosingandefficacyofnewimmunetherapies AT gastineaudennis usingwholeimmunesystemcharacterizationimmuneprofilingtoidentifyimmunebiomarkerstodeterminepatientselectiondosingandefficacyofnewimmunetherapies AT parneyian usingwholeimmunesystemcharacterizationimmuneprofilingtoidentifyimmunebiomarkerstodeterminepatientselectiondosingandefficacyofnewimmunetherapies AT dietzallan usingwholeimmunesystemcharacterizationimmuneprofilingtoidentifyimmunebiomarkerstodeterminepatientselectiondosingandefficacyofnewimmunetherapies |